The Brain & Behavior Research Foundation’s site answers frequently asked questions about mental illnesses, including schizophrenia, and discusses research advances in treating and understanding these illnesses.
Mental Health America, formerly the National Mental Health Association, provides information about many forms of mental illness, treatment options, and medication resources. In addition, free brochures and reports are available.
The National Alliance on Mental Illness Web site houses resources on a host of mental illnesses, such as depression, obsessive-compulsive disorder, and borderline personality disorder. The site also provides information on treatments, support groups, and recovery from mental illness.
This National Institute of Mental Health page provides information about the symptoms, treatments, and current research on schizophrenia.
How to Reduce Your Risk of Alzheimer’s Without Taking Drugs
While most cases of dementia may be unavoidable, a great many may be prevented or delayed via simple changes in diet and other habits. In principle, the earlier in life a person starts making these changes, the better the preventive effect would be.
(Read Q&A with Patrick F. Sullivan, M.D., FRANZCP)
In July 2014, an international consortium of schizophrenia researchers mounted the largest biological experiment in the
history of psychiatry. With many more avenues for exploring the biological
underpinnings of schizophrenia now available to neuroscientists, hope may be on
the way for the estimated 2.4 million Americans and 1 in 100 people worldwide
affected by the illness, one in which drugs have limited impact and there is no
Could the disorder—often characterized by hearing voices—be a failure of brain rhythms?
Our understanding of the biological mechanisms of schizophrenia risk has steadily evolved over the past few decades, attributable largely to advances in human genetics and to genomic technologies. One of our series of Reports on Progress.
(Read Q&A with Sir Robin Murray, M.D.)
Studies that have tied cannabis use to schizophrenia in the developing brain are just the tip of the iceberg when it comes to marijuana. Our author, a noted British psychiatrist, offers a European perspective on issues such as the dangers of synthetic cannabinoids, dependence and cognitive impairment, and the implications of legalization.
Scientists are finding evidence that neuroinflammation can alter mood and cognition, perhaps enough to help cause psychiatric disorders.